Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul-Sep;22(3):301-6.
doi: 10.4103/0973-1075.185041.

Comparative Evaluation of Retrocrural versus Transaortic Neurolytic Celiac Plexus Block for Pain Relief in Patients with Upper Abdominal Malignancy: A Retrospective Observational Study

Affiliations

Comparative Evaluation of Retrocrural versus Transaortic Neurolytic Celiac Plexus Block for Pain Relief in Patients with Upper Abdominal Malignancy: A Retrospective Observational Study

Saipriya Tewari et al. Indian J Palliat Care. 2016 Jul-Sep.

Abstract

Aim: To compare retrocrural versus transaortic techniques for neurolytic celiac plexus block (NCPB) in patients suffering from upper abdominal malignancy.

Methods: In this retrospective observational study between October 2013 and April 2015, 64 patients with inoperable upper abdominal malignancy received fluoroscopy-guided percutaneous NCPB in our institute. Their case files were reviewed and the patients were divided into two groups depending on the technique used to perform NCPB: retrocrural (Group R; n = 36) versus transaortic (Group T; n = 28). The primary outcome measure was pain as assessed with a numeric rating scale (NRS) from 0 to 10; the secondary outcome measures were morphine consumption per day (M), quality of life (QOL) as assessed by comparing the percent of positive responses in each group, and complications if any. These were noted and analyzed prior to intervention and then on day 1, weeks 1, 2, 3, and months 1, 2, 3, 6 following NCPB.

Results: Patients in Group R had significantly reduced NRS pain scores at week 1, 2, 3, month 1 and 2 as compared to Group T (P < 0.05). Morphine consumption also reduced significantly in Group R at day 1, week 1, 2, and 3 (P < 0.05). QOL was found to be comparable between the groups, and no major complications were noted.

Conclusion: Retrocrural NCPB provides superior pain relief along with a reduction in morphine consumption as compared to transaortic NCPB in patients with pain due to upper abdominal malignancy.

Keywords: Neurolytic celiac plexus block; Retrocrural; Transaortic; Upper abdominal cancer pain.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a-f) C-arm guided retrocrural technique for celiac plexus block
Figure 2
Figure 2
(a-d) C-arm guided transaortic technique for celiac plexus block
Figure 3
Figure 3
Pain as assessed by numeric rating scale in the various groups. Data are presented as a mean ± standard deviation. *P < 0.05 during within the group comparison. #P < 0.05 during between group comparison
Figure 4
Figure 4
Morphine consumption in the various groups. Data are presented as a mean ± standard deviation. *P < 0.05 during within the group comparison. #P < 0.05 during between group comparison

Similar articles

Cited by

References

    1. Goudas L, Carr DB, Bloch R, Balk E, Ioannidis JP, Terrin N, et al. Management of cancer pain. Evid Rep Technol Assess (Summ) 2001;35:1–5. - PMC - PubMed
    1. Polati E, Luzzani A, Schweiger V, Finco G, Ischia S. The role of neurolytic celiac plexus block in the treatment of pancreatic cancer pain. Transplant Proc. 2008;40:1200–4. - PubMed
    1. Morturano RA, Dunphy EP. Celiac plexus block in pancreatic neuroendocrine tumors. Clin J Oncol Nurs. 2011;15:218–20. - PubMed
    1. Nagels W, Pease N, Bekkering G, Cools F, Dobbels P. Celiac plexus neurolysis for abdominal cancer pain: A systematic review. Pain Med. 2013;14:1140–63. - PubMed
    1. Mercadante S, Klepstad P, Kurita GP, Sjøgren P, Giarratano A. European Palliative Care Research Collaborative (EPCRC). Sympathetic blocks for visceral cancer pain management: A systematic review and EAPC recommendations. Crit Rev Oncol Hematol. 2015;96:577–83. - PubMed